SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-011796
Filing Date
2020-08-05
Accepted
2020-08-05 16:19:02
Documents
17
Period of Report
2020-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sgmo-20200805.htm   iXBRL 8-K 56685
2 EX-99.1 exhibit-991.htm EX-99.1 98894
8 logo11.gif GRAPHIC 43773
9 opextable11.gif GRAPHIC 11161
  Complete submission text file 0001628280-20-011796.txt   383821

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20200805.xsd EX-101.SCH 2462
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgmo-20200805_cal.xml EX-101.CAL 747
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgmo-20200805_def.xml EX-101.DEF 1693
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20200805_lab.xml EX-101.LAB 24270
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20200805_pre.xml EX-101.PRE 12683
10 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20200805_htm.xml XML 10757
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 201077588
SIC: 2836 Biological Products, (No Diagnostic Substances)